Bausch Health Companies Inc. (BHC) [Rocket]

Date Filed	Type	Description
02/08/2021	GN	Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting
11/12/2020	GN	Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
09/23/2020	GN	Clearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publication of XIPERE™ Data in Diabetic Macular Edema in Ophthalmology Retina
09/03/2020	GN	Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii®
06/29/2020	GN	Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
08/20/2018	GN	RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation
05/07/2018	GN	Safirstein Metcalf LLP and HGT Law Remind Investors That a Shareholder Opt-out Lawsuit was Filed on Behalf of Retail Investors and Invite Investors to Contact the Firms - VRX
04/09/2018	GN	New Research Coverage Highlights SINOPEC Shangai Petrochemical, Aurinia Pharmaceuticals, Valeant Pharmaceuticals International, NTT DOCOMO, Southern Missouri, and KNOT Offshore Partners LP — Consolidated Revenues, Company Growth, and Expectations for 2018
04/06/2018	GN	EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
03/14/2018	GN	Report: Developing Opportunities within NRG Yield, Stitch Fix, Encana, Valeant Pharmaceuticals International, Orbotech, and CoreCivic, Inc. — Future Expectations, Projections Moving into 2018
01/29/2018	GN	Safirstein Metcalf LLP and HGT Law Commence a Securities Fraud Action Against Valeant Pharmaceuticals and its Senior Officers on Behalf of Retail Investors - VRX